Skip to main content

EDITORIAL article

Front. Cardiovasc. Med.
Sec. Hypertension
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1463305
This article is part of the Research Topic Therapeutics in Pulmonary Arterial Hypertension View all 10 articles

Editorial: Therapeutics in Pulmonary Arterial Hypertension

Provisionally accepted
Rui Adão Rui Adão 1,2*Francisco Perez-Vizcaino Francisco Perez-Vizcaino 2Bassam Redwan Bassam Redwan 3Carmen Brás-Silva Carmen Brás-Silva 1
  • 1 Cardiovascular Research Unit, Faculty of Medicine, University of Porto, Porto, Portugal
  • 2 Department of Pharmacology and Toxicology, Faculty of Medicine, Complutense University of Madrid, Madrid, Madrid, Spain
  • 3 Faculty of Medicine, University of Witten Herdecke, Witten, Germany, Witten, Germany

The final, formatted version of the article will be published soon.

    Keywords: pulmonary hypertension, right ventricle, Vascular Diseases, Right heart failure, therapy, endothelial dysfunction, Pulmonary vascular remodeling

    Received: 11 Jul 2024; Accepted: 22 Jul 2024.

    Copyright: © 2024 Adão, Perez-Vizcaino, Redwan and Brás-Silva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Rui Adão, Cardiovascular Research Unit, Faculty of Medicine, University of Porto, Porto, Portugal

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.